 |
Doxorubicin hydrochloride in a lipid-based pegylated nanoparticle modified with a 31-aminoacid peptide targeting nucleolin |
|---|---|
| Trade Name | |
| Orphan Indication | Malignant pleural mesothelioma |
| EU Market Approval | EU |
| EU Designation Date | 2017-01-12 00:00:00 |
| Sponsor | TREAT U, S.A. |
